Orthopaedics Grand Rounds 2026 - 1/30/2026 - Soft Tissue Defects of the Extremities: Why Orthopedic Surgeons Should Choose What to Use - Martin Boyer, MD

Friday, January 30, 2026, 6:45 AM - 7:45 AM, Dartmouth Hitchcock Medical Center, Lebanon, NH

AMA PRA Category 1 Credits™ (1.00 hours), CME-Designated Participation Credit (1.00 hours)

Friday, 6:45 to 7:45 am (location varies)

For information on how to participate in Orthopaedic Grand Rounds via Webex, please email [email protected].

Objective(s): 1 Discuss at least three updates to the role and responsibility of the members of the orthopaedic team from the following list of items: best practice treatment plans and guidelines, surgical procedures, shared decision-making and interprofessional communication techniques.
Location: Dartmouth Hitchcock Medical Center

Faculty Disclosures:
Martin Boyer, MD (Nothing to disclose - 12/30/2025)
Download Handout

1. Discuss at least three updates to the role and responsibility of the members of the orthopaedic team from the following list of items: best practice treatment plans and guidelines, surgical procedures, shared decision-making and interprofessional communication techniques.

In support of improving patient care, Dartmouth Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

American Medical Association (AMA)
Dartmouth Health designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Mitigation of Relevant Financial Relationships

Dartmouth Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.  Any individuals in a position to control the content of a CE activity, including planners, faculty, authors, or others are required to disclose all financial relationships with ineligible companies^.  All relevant financial relationships have been mitigated prior to the commencement of the activity.

^Ineligible Company is any entity whose primary business purpose is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.